Literature DB >> 20568118

Dab1 binds to Fe65 and diminishes the effect of Fe65 or LRP1 on APP processing.

Oh Yeun Kwon1, Kyounghee Hwang, Jeom-A Kim, Kwangmyung Kim, Ick Chan Kwon, Hyun Kyu Song, Hyesung Jeon.   

Abstract

Fe65 and Dab1 are adaptor proteins that interact with the cytoplasmic domain of amyloid precursor protein (APP) via phosphotyrosine-binding (PTB) domain and that affect APP processing and Aβ production. Co-expression of Dab1 with Fe65 and APP resumed nuclear translocation of Fe65 despite of its cytoplasmic anchor, APP. The decreased amount of Fe65 bound to APP was shown in co-immunoprecipitation assay from the cells with Dab1 which also displayed the effect on APP processing. These data suggested that Fe65 and Dab1 compete for binding to APP. Surprisingly, we found that Fe65 interacts with Dab1 via C-terminal region of Dab1 and unphosphorylated Dab1 is capable of binding Fe65. Dab1 interacts with the low-density lipoprotein receptor-related protein (LRP) as well as APP through its PTB domain. Dab1 significantly decreased the amount of APP bound to LRP and the level of secreted APP and APP-CTF in LRP expressing cells, unlike Fe65. It implies that overexpression of Dab1 diminish LRP-APP complex formation, resulting in altered APP processing. The competition for overlapped binding site among adaptor proteins may be related to the regulation mechanism of APP metabolism in various conditions.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568118     DOI: 10.1002/jcb.22738

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Reelin protects against amyloid β toxicity in vivo.

Authors:  Courtney Lane-Donovan; Gary T Philips; Catherine R Wasser; Murat S Durakoglugil; Irene Masiulis; Ajeet Upadhaya; Theresa Pohlkamp; Cagil Coskun; Tiina Kotti; Laura Steller; Robert E Hammer; Michael Frotscher; Hans H Bock; Joachim Herz
Journal:  Sci Signal       Date:  2015-07-07       Impact factor: 8.192

Review 2.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 3.  Regulation of β cleavage of amyloid precursor protein.

Authors:  Jun-Feng Wang; Rui Lu; Yi-Zheng Wang
Journal:  Neurosci Bull       Date:  2010-10       Impact factor: 5.203

4.  A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly.

Authors:  V Chouraki; R F A G De Bruijn; J Chapuis; J C Bis; C Reitz; S Schraen; C A Ibrahim-Verbaas; B Grenier-Boley; C Delay; R Rogers; F Demiautte; A Mounier; A L Fitzpatrick; C Berr; J-F Dartigues; A G Uitterlinden; A Hofman; M Breteler; J T Becker; M Lathrop; N Schupf; A Alpérovitch; R Mayeux; C M van Duijn; L Buée; P Amouyel; O L Lopez; M A Ikram; C Tzourio; J-C Lambert
Journal:  Mol Psychiatry       Date:  2014-02-18       Impact factor: 15.992

5.  The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease?

Authors:  Daniel A Bórquez; Christian González-Billault
Journal:  Int J Alzheimers Dis       Date:  2012-02-09

Review 6.  Functional Roles of the Interaction of APP and Lipoprotein Receptors.

Authors:  Theresa Pohlkamp; Catherine R Wasser; Joachim Herz
Journal:  Front Mol Neurosci       Date:  2017-03-01       Impact factor: 5.639

7.  Physiological significance of proteolytic processing of Reelin revealed by cleavage-resistant Reelin knock-in mice.

Authors:  Eisuke Okugawa; Himari Ogino; Tomofumi Shigenobu; Yuko Yamakage; Hitomi Tsuiji; Hisashi Oishi; Takao Kohno; Mitsuharu Hattori
Journal:  Sci Rep       Date:  2020-03-11       Impact factor: 4.379

Review 8.  Canonical and Non-canonical Reelin Signaling.

Authors:  Hans H Bock; Petra May
Journal:  Front Cell Neurosci       Date:  2016-06-30       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.